{
    "organizations": [],
    "uuid": "a72e079ca3b4ca59f51d5e9daeddb24e0dd72e52",
    "author": "",
    "url": "https://www.reuters.com/article/brief-moderna-and-merck-expand-mrna-canc/brief-moderna-and-merck-expand-mrna-cancer-vaccines-collaboration-idUSB8N1LI03L",
    "ord_in_thread": 0,
    "title": "BRIEF-Moderna And Merck Expand MRNA Cancer Vaccines Collaboration",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Merck & Co Inc:\n* MODERNA AND MERCK EXPAND MRNA CANCER VACCINES COLLABORATION\n* MERCK SAYS EXPANSION INCLUDES JOINT DEVELOPMENT OF MODERNAâ€™S KRAS ONCOGENE PROGRAM, OTHER POTENTIAL MRNA CANCER VACCINES\n* MERCK SAYS CO WILL MAKE $125 MILLION INVESTMENT IN MODERNA IN NEWLY PRICED SERIES H PREFERRED EQUITY\n* MERCK - CO, MODERNA TO NOW ADVANCE JOINTLY MRNA-5671 IN HUMAN STUDIES, PLAN TO CONDUCT COMBINATION STUDIES WITH ADDITIONAL IMMUNO-ONCOLOGY THERAPIES\n* MERCK - CO TO BE RESPONSIBLE FOR CLINICAL DEVELOPMENT OF MRNA-5671, ASSOCIATED COSTS; MODERNA TO BE RESPONSIBLE FOR CLINICAL SUPPLY, ASSOCIATED COSTS\n* MERCK - FOLLOWING HPOC STUDIES, CO MAY OPT-IN ON FURTHER DEVELOPMENT, COMMERCIALIZATION OF MRNA-5671 UPON PAYMENT OF UNDISCLOSED FEE TO MODERNA\n* MERCK SAYS FOLLOWING OPT-IN, PARTIES WILL SHARE EQUALLY GLOBAL NET PROFITS, COSTS ASSOCIATED WITH MRNA-5671 Source text for Eikon:\nOur ",
    "published": "2018-05-04T00:58:00.000+03:00",
    "crawled": "2018-05-04T01:14:59.026+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "merck",
        "co",
        "inc",
        "moderna",
        "merck",
        "expand",
        "mrna",
        "cancer",
        "vaccine",
        "collaboration",
        "merck",
        "say",
        "expansion",
        "includes",
        "joint",
        "development",
        "moderna",
        "kras",
        "oncogene",
        "program",
        "potential",
        "mrna",
        "cancer",
        "vaccine",
        "merck",
        "say",
        "co",
        "make",
        "million",
        "investment",
        "moderna",
        "newly",
        "priced",
        "series",
        "h",
        "preferred",
        "equity",
        "merck",
        "co",
        "moderna",
        "advance",
        "jointly",
        "human",
        "study",
        "plan",
        "conduct",
        "combination",
        "study",
        "additional",
        "therapy",
        "merck",
        "co",
        "responsible",
        "clinical",
        "development",
        "associated",
        "cost",
        "moderna",
        "responsible",
        "clinical",
        "supply",
        "associated",
        "cost",
        "merck",
        "following",
        "hpoc",
        "study",
        "co",
        "may",
        "development",
        "commercialization",
        "upon",
        "payment",
        "undisclosed",
        "fee",
        "moderna",
        "merck",
        "say",
        "following",
        "party",
        "share",
        "equally",
        "global",
        "net",
        "profit",
        "cost",
        "associated",
        "source",
        "text",
        "eikon"
    ]
}